[1]
2025. Efficacy and Safety of SGLT2 Inhibitors in Non-Diabetic Patients with Heart Failure: A Systematic Review and Meta-Analysis. Vascular and Endovascular Review. 8, 4s (Oct. 2025), 395–401. DOI:https://doi.org/10.64149/J.Ver.8.4s.395-401.